Markets:

Overview

News

Currencies

International

Treasuries

MoonLake Immunotherapeutics - Class A Ordinary Shares (NQ:MLTX)

17.95 -0.87 (-4.62%)

Streaming Delayed Price Updated: 2:43 PM EDT, Jun 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about MoonLake Immunotherapeutics - Class A Ordinary Shares

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

MoonLake Immunotherapeutics to host a Capital Markets Day on Monday, September 11

September 06, 2023

From MoonLake Immunotherapeutics AG

Via GlobeNewswire

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

August 31, 2023

Via Benzinga

Skin Disease Focused MoonLake Immunotherapeutics Poised To Outshine Rivals, Analyst Asserts ↗

August 31, 2023

Needham initiated coverage on MoonLake Immunotherapeutics (NASDAQ: MLTX) with a Buy rating and

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 31, 2023 ↗

August 31, 2023

Via Benzinga

Expert Ratings for MoonLake ↗

August 31, 2023

Via Benzinga

10 Analysts Have This to Say About MoonLake ↗

August 14, 2023

Via Benzinga

The 7 Most Promising Momentum Stocks to Own Now ↗

August 31, 2023

These momentum stock picks are on a run, but it isn't too late to ride the rollercoaster amid broad market volatility.

Via InvestorPlace

MoonLake Immunotherapeutics Reports Second Quarter 2023 Financial Results and Provides a Business Update

August 10, 2023

From MoonLake Immunotherapeutics AG

Via GlobeNewswire

Analyst Expectations for MoonLake's Future ↗

July 26, 2023

Via Benzinga

MoonLake completes patient randomization ahead of schedule for its Phase 2 trial in active psoriatic arthritis (PsA) and provides calendar of next readouts

July 25, 2023

From MoonLake Immunotherapeutics AG

Via GlobeNewswire

10 Short Squeeze Stocks To Watch: Baosheng Media, Toro Corp, Getty Images And More ↗

July 18, 2023

Potential short squeeze plays gained steam in 2021, continued throughout 2022, and remain a focus of new traders looking for the next huge move. High short interest and steep borrowing costs are among...

Via Benzinga

Where MoonLake Stands With Analysts ↗

July 03, 2023

Via Benzinga

Why MoonLake Immunotherapeutics Stock Skyrocketed This Week ↗

June 29, 2023

Positive mid-stage results fueled a spike in the biotech's shares this week.

Via The Motley Fool

Price Target For MoonLake Doubled: Analyst Says Lead Program Has 'Best-In-Class Profile' ↗

July 17, 2023

HC Wainwright has increased the price target for MoonLake Immunotherapeutics (NASDAQ: MLTX) from $37 to $75

Via Benzinga

Ford Motor Cuts Prices For F-150 Lightning Truck, Microsoft-Sony Sign Agreement for 'Call of Duty,' Alibaba Stock Slips on China's Q2 GDP Sentiment: Today's Top Stories ↗

July 17, 2023

Benzinga

Via Benzinga

MoonLake's Potential Sale: Stock Price Up Fivefold Since Public Debut In 2022 ↗

July 17, 2023

MoonLake Immunotherapeutics (NASDAQ: MLTX) has reportedly engaged an investment bank as the Swiss company looks for a potential sale. The company focuses on developing antibody-derived treatments for...

Via Benzinga

10 Short Squeeze Stocks To Watch: Asset Entities, Lightning eMotors, Bullfrog AI, Carvana And More ↗

July 10, 2023

Via Benzinga

Why Shares of MoonLake Immunotherapeutics Skyrocketed Monday ↗

June 26, 2023

The company reported positive phase 2 clinical trial results.

Via The Motley Fool

$40M Bet On MoonLake Immunotherapeutics? Check Out These 3 Stocks Insiders Are Buying ↗

July 06, 2023

Although US stocks closed lower on Wednesday, there were a few notable insider trades.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

July 04, 2023

Via Benzinga

10 Short Squeeze Stocks To Watch: A Leader That Moved Up 392 Positions, Intuitive Machines, Toro And More ↗

July 03, 2023

Via Benzinga

MarketBeat Week in Review – 6/26 - 6/30

July 01, 2023

Markets headed into a holiday week cheering a lower-than-expected key inflation reading, but investors should expect volatility in a short trading week.

Via MarketBeat

Topics Economy

Stock Market Rally Roars Back Toward Highs; Carnival, Delta, Micron, Nvidia In Focus: Weekly Review ↗

June 30, 2023

Major indexes rebounded strongly and many stocks flashed buy signals.

Via Investor's Business Daily

MoonLake Immunotherapeutics Makes a Moonshot on Trials

June 28, 2023

Clinical-stage biotech MoonLake Immunotherapeutics AG (NASDAQ: MLTX) shares spiked 70% on positive clinical trial results.

Via MarketBeat

MoonLake Immunotherapeutics Announces Pricing of $400 Million Upsized Public Offering of Class A Ordinary Shares

June 28, 2023

From MoonLake Immunotherapeutics AG

Via GlobeNewswire

Why MoonLake Immunotherapeutics Was Such a Healthy Stock Today ↗

June 27, 2023

The heavily bullish sentiment on the company only grew on the second trading day of the week.

Via The Motley Fool

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

June 27, 2023

Via Benzinga

MoonLake Immunotherapeutics, Applied Digital And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗

June 27, 2023

U.S. stock futures traded slightly higher this morning. Here are some big stocks recording losses in today’s pre-market trading session.

Via Benzinga

BioMedNewsBreaks – MoonLake Immunotherapeutics’ (NASDAQ: MLTX) Shares See Significant Increase Based on Success of Phase 2 Trial

June 26, 2023

Via Investor Brand Network

Dow Surges Over 50 Points; Avalo Therapeutics Shares Plummet ↗

June 26, 2023

U.S. stocks traded mixed toward the end of trading, with the Dow Jones gaining more than 50 points on Monday. The Dow traded up 0.18% to 33,788.05 while the NASDAQ fell 0.61% to 13,410.63. The S&P 500,...

Via Benzinga

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.